3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
211
Neoplasm Metastasis
16
Neoplasms
9
Breast Neoplasms, Male
7
Breast Diseases
7
Ovarian Neoplasms
4
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Intraductal, Noninfiltrating
3
Breast Carcinoma In Situ
3
Breast Cancer Metastatic
3
Advanced Breast Cancer
3
Recurrence
2
Prostatic Neoplasms
2
Neoplasms by Site
2
Carcinoma, Renal Cell
2
Bulbo-Spinal Atrophy, X-Linked
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Wake Disorders
1
Skin Diseases
1
Sexuality
1
Sexual Dysfunctions, Psychological
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Primary Breast Cancer ER+ve
1
Interventions
Yoga
2
Methylphenidate
2
Melatonin
2
Educational Status
2
Early Intervention, Educational
2
Counseling
2
Cognitive Behavioral Therapy
2
Behavior Therapy
2
exemestane
1
Zolpidem
1
Venlafaxine Hydrochloride
1
Valeriana extract
1
Uncertainty
1
Ultraviolet Therapy
1
Triptorelin Pamoate
1
Therapeutics
1
Tamoxifen
1
Surveys and Questionnaires
1
Saline Solution
1
Psychosocial Intervention
1
Phototherapy
1
N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide
1
Modafinil
1
Methods
1
Methadone
1
Hypnosis
1
Gonadotropin-Releasing Hormone
1
Exercise Test
1
Donepezil
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sleep Wake Disorders
×
exemestane
×
Clear all
NCT00659373
2016-07-25
Co-SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
86 enrolled
4 charts